NCT04939922Recruiting
China Headache and Vertigo Registry Study
Source: ClinicalTrials.gov · Last updated 25 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In the Chinese Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 14 Jun 2021
- Start date
- 12 Jun 2017
- Primary completion date
- 12 Dec 2050
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Migraine
- NCT number
- NCT04939922
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 12 Jun 2017 to the primary completion date, 12 Dec 2050
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who were unable to complete scales such as headache diary.
- Patients denied or unable to be admitted for long-term follow-up.
Who the study is looking for
- Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures.
- Male or female participants ages 4 to 99 years.
- Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches.
- Patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine).
Age in the registry: 4 years to 99 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaiming Liu Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
Related publications
- Effectiveness of rimegepant in vestibular migraine: a prospective self-controlled cohort study.J Headache Pain · 2025 · PMID 41430107
This page is information, not medical advice. Discuss any trial with your doctor.